World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
52371
World Ranking
9484
National Ranking
4893

Overview

Rebecca Gelman is affiliated with Harvard University in the United States. Their research primarily focuses on medicine and biochemistry, genetics, and molecular biology, with particular attention to oncology, pulmonary and respiratory medicine, and genetics. The work also touches on cancer research and surgery.

The scientist's research topics encompass a range of areas related to cancer and treatment, including:

  • BRCA gene mutations in cancer
  • Cancer treatment and pharmacology
  • Brain metastases and treatment
  • HER2/EGFR in cancer research
  • PARP inhibition in cancer therapy
  • Advanced breast cancer therapies
  • Breast cancer treatment studies

Recent publications authored or coauthored by Rebecca Gelman include:

  • "Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100,800 women from 86 randomised trials," 2023, The Lancet
  • "Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases," 2020, Breast Cancer Research
  • "The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034)," 2020, Annals of Surgical Oncology
  • "Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations," 2021, Breast Cancer Research and Treatment
  • "Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial," 2023, JCO Oncology Practice

Frequent coauthors collaborating with Gelman include:

  • Eric P. Winer
  • Michelle Weitz
  • Judy E. Garber
  • Nancy U. Lin
  • Huma Q. Rana

Their work has been published in venues such as UNC Libraries, The Lancet, JCO Oncology Practice, Breast Cancer Research, and Annals of Surgical Oncology. Gelman's contributions are marked by multiple papers across these journals, with UNC Libraries featuring two publications.

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

    C Focan;SM Steinberg;M Blichert-Toft;JF Forbes

  • Molecular Definition of Breast Tumor Heterogeneity

    Michail Shipitsin;Lauren L. Campbell;Pedram Argani;Stanislawa Weremowicz

  • Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

    Daniel P. Silver;Andrea L. Richardson;Aron C. Eklund;Zhigang C. Wang

  • Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination

    Dan H. Barouch;Sampa Santra;Jörn E. Schmitz;Marcelo J. Kuroda

  • Intracranial germ-cell tumors: natural history and pathogenesis.

    Mark T. Jennings;Rebecca Gelman;Fred Hochberg

  • Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

    Johanna C. Bendell;Susan M. Domchek;Harold J. Burstein M.D.;Lyndsay Harris

  • Lymphocyte subsets in healthy children from birth through 18 years of age : The pediatric AIDS clinical trials group P1009 study

    William T. Shearer;Howard M. Rosenblatt;Rebecca S. Gelman;Rebecca Oyomopito

  • Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer.

    Asa J. Nixon;Donna Neuberg;Daniel F. Hayes;Rebecca Gelman

  • Outcome at 8 Years After Breast-Conserving Surgery and Radiation Therapy for Invasive Breast Cancer: Influence of Margin Status and Systemic Therapy on Local Recurrence

    Catherine C. Park;Michihide Mitsumori;Asa Nixon;Abram Recht

  • Network modeling links breast cancer susceptibility and centrosome dysfunction.

    Miguel Angel Pujana;Jing Dong J Han;Lea M. Starita;Kristen N. Stevens

  • The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast‐conserving surgery and radiation therapy

    Stuart J. Schnitt;Anthony Abner;Rebecca Gelman;James L. Connolly

  • The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer.

    Recht A;Come Se;Henderson Ic;Gelman Rs

  • Regulation of In Situ to Invasive Breast Carcinoma Transition

    Min Qi Hu;Jun Yao;Danielle K. Carroll;Stanislawa Weremowicz

  • Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria.

    Stuart J. Schnitt;James L. Connolly;Fattaneh A. Tavassoli;Robert E. Fechner

  • The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast.

    Roland Holland;James L. Connolly;Rebecca Gelman;Marcel Mravunac

  • Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.

    Nancy U. Lin;Lisa A. Carey;Minetta C. Liu;Jerry Younger

  • Clinical Activity of Trastuzumab and Vinorelbine in Women With HER2-Overexpressing Metastatic Breast Cancer

    Harold J. Burstein;Irene Kuter;Susana M. Campos;Rebecca S. Gelman

  • Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

    Harold J. Burstein;Lyndsay N. Harris;P. Kelly Marcom;Rosemary Lambert-Falls

  • Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy.

    Irene Gage;Irene Gage;Stuart J. Schnitt;Asa J. Nixon;B A Barbara Silver

Frequent Co-Authors

Jay R. Harris
Jay R. Harris Brigham and Women's Hospital
Abram Recht
Abram Recht Beth Israel Deaconess Medical Center
Stuart J. Schnitt
Stuart J. Schnitt Brigham and Women's Hospital
Eric P. Winer
Eric P. Winer Yale University
James L. Connolly
James L. Connolly Beth Israel Deaconess Medical Center
Harold J. Burstein
Harold J. Burstein Harvard University
Judy Garber
Judy Garber Harvard University
Norman L. Letvin
Norman L. Letvin Beth Israel Deaconess Medical Center
Ian E. Krop
Ian E. Krop Harvard University
Kornelia Polyak
Kornelia Polyak Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine offers diverse career pathways, and online degrees now make it easier to upskill or specialize. For nurses aspiring to advanced roles in mental health, the fastest post master's pmhnp programs provide a flexible route to becoming a Psychiatric Mental Health Nurse Practitioner, allowing you to complete your studies at an accelerated pace.

Healthcare management is also in high demand. Individuals interested in leadership, policy, or hospital administration may consider competing for roles by pursuing the best online mha programs. These programs often accommodate working professionals and can be a smart option for those conscious of costs.

Financial considerations are central when choosing your education path. Understanding masters in healthcare administration cost can help you make informed decisions about tuition and return on investment.

Finally, those aiming for the highest clinical leadership should explore cheap dnp online programs, which deliver advanced nursing education at a lower cost, maximizing career potential without excessive financial burden.

Best Scientists Citing Rebecca Gelman

Trending Scientists

Recently Published Articles